Literature DB >> 19577304

Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction.

Grith L Sorensen1, Silje V Hoegh, Rikke Leth-Larsen, Theresa H Thomsen, Charlotte Floridon, Kelly Smith, Karin Kejling, Ida Tornoe, Erika C Crouch, Uffe Holmskov.   

Abstract

Surfactant protein-D (SP-D) is a calcium dependent lectin in the innate immune system that facilitates clearance of microbes. The protein is associated with mucosal surfaces, and also found in bronchoalveolar lavage, serum and amniotic fluid. Human SP-D includes trimeric subunits and multimeric assemblies of trimeric subunits, which are stabilized by N-terminal interchain disulfide crosslinks. An N-terminal structural polymorphism (Met11Thr) and associated O-glycosylation are previously shown accompanied by incomplete multimerization and with a relative low proportion of multimeric Thr11 SP-D compared to Met11 SP-D. Multimerization has proven important for enhancement of microbial phagocytosis. In the present study defined multimeric forms of Met11Thr SP-D were isolated from human amniotic fluid. Implementation of ManNAc-affinity chromatography allowed high recovery of natural trimeric SP-D subunits. However, affinity chromatography increased the relative proportion of multimers at the expense of natural trimeric subunits. Multimeric SP-D partially disassembled to form trimeric subunits. The resulting distribution of structural forms was independent of the Met11Thr genotype. Trimeric and multimeric SP-D appeared with distinct patterns of disulphide crosslinking, which partly changed according to interconversion between the structural forms. Solid phase assays demonstrated that trimeric SP-D subunits showed greater binding to LPS and PGN, but lower binding to mannan and LTA, than SP-D multimers. Trimeric SP-D subunits also showed greater binding to endogenous lipoproteins: LDL, oxLDL, and HDL, than multimeric SP-D. In conclusion, purified trimeric and multimeric SP-D represent separate and only partly interconvertible molecular populations with distinct biochemical properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577304     DOI: 10.1016/j.molimm.2009.06.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Surfactant protein D (SP-D) deficiency is attenuated in humanised mice expressing the Met(11)Thr short nucleotide polymorphism of SP-D: implications for surfactant metabolism in the lung.

Authors:  Lars Knudsen; Katharina Ochs; Laura Boxler; Ida Tornoe; Grith Lykke-Sorensen; Rose-Marie Mackay; Howard W Clark; Uffe Holmskov; Matthias Ochs; Jens Madsen
Journal:  J Anat       Date:  2013-09-23       Impact factor: 2.610

2.  Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis.

Authors:  Anne Friesgaard Christensen; Grith Lykke Sørensen; Kim Hørslev-Petersen; Uffe Holmskov; Hanne Merete Lindegaard; Kirsten Junker; Merete Lund Hetland; Kristian Stengaard-Pedersen; Søren Jacobsen; Tine Lottenburger; Torkell Ellingsen; Lis Smedegaard Andersen; Ib Hansen; Henrik Skjødt; Jens Kristian Pedersen; Ulrik Birk Lauridsen; Anders Svendsen; Ulrik Tarp; Jan Pødenphant; Aage Vestergaard; Anne Grethe Jurik; Mikkel Østergaard; Peter Junker
Journal:  Arthritis Res Ther       Date:  2010-03-08       Impact factor: 5.156

3.  Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia.

Authors:  Jacob V Stidsen; Reza Khorooshi; Martin K U Rahbek; Katrine L Kirketerp-Møller; Pernille B L Hansen; Peter Bie; Karin Kejling; Susanne Mandrup; Samuel Hawgood; Ole Nielsen; Claus H Nielsen; Trevor Owens; Uffe Holmskov; Grith L Sørensen
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

4.  Surfactant protein-D (SP-D) gene polymorphisms and serum level as predictors of susceptibility and prognosis of acute kidney injury in the Chinese population.

Authors:  Jiao Liu; Guang Li; Lianghai Li; Zhiyong Liu; Qingshan Zhou; Guirong Wang; Dechang Chen
Journal:  BMC Nephrol       Date:  2017-02-17       Impact factor: 2.388

Review 5.  SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.

Authors:  Alastair Watson; Jens Madsen; Howard William Clark
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

6.  The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.

Authors:  Alaa Zien Alaabden; Yousser Mohammad; Sahar Fahoum
Journal:  Qatar Med J       Date:  2016-01-26

Review 7.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08

8.  Generation of novel trimeric fragments of human SP-A and SP-D after recombinant soluble expression in E. coli.

Authors:  Alastair Watson; Grith L Sørensen; Uffe Holmskov; Harry J Whitwell; Jens Madsen; Howard Clark
Journal:  Immunobiology       Date:  2020-05-27       Impact factor: 3.144

9.  Functional Analysis of Genetic Variations in Surfactant Protein D in Mycobacterial Infection and Their Association With Tuberculosis.

Authors:  Miao-Hsi Hsieh; Chih-Ying Ou; Wen-Yu Hsieh; Hui-Fang Kao; Shih-Wei Lee; Jiu-Yao Wang; Lawrence S H Wu
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

10.  Systematic Review and Meta-Analysis Confirms Significant Contribution of Surfactant Protein D in Chronic Obstructive Pulmonary Disease.

Authors:  Debparna Nandy; Nidhi Sharma; Sabyasachi Senapati
Journal:  Front Genet       Date:  2019-04-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.